Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents

COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of symptom severity that requires varying amounts of care according to the different stages of the disease. Intervening at the onset of mild to moderate COVID-19 symptoms in the outpatient setting would provide the opportunity to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Perico, Norberto, Cortinovis, Monica, Suter, Fredy, Remuzzi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411261/
https://www.ncbi.nlm.nih.gov/pubmed/36030796
http://dx.doi.org/10.1016/S1473-3099(22)00433-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411261/
https://www.ncbi.nlm.nih.gov/pubmed/36030796
http://dx.doi.org/10.1016/S1473-3099(22)00433-9

Ejemplares similares